Union Minister of State for Health and Family Welfare, Anupriya Patel, recently inaugurated the National Virus Research & Diagnostic Laboratory (VRDL) Conclave 2025. This significant event underscored the pivotal role of India’s health research in safeguarding the nation. Indeed, our VRDLs have truly stood as sentinels in protecting the country, especially throughout the COVID-19 pandemic and beyond. [1]
Strengthening Diagnostic Capabilities Across India
During the conclave, Minister Patel announced the new In-Vitro Diagnostics (IVD) validation portal. This portal aims to make validation processes faster, more transparent, and industry-friendly. [1] Early detection of outbreaks and indigenous test validations demonstrate India’s commitment to setting benchmarks in health research innovation. The Department of Health Research (DHR), ICMR, and VRDLs received commendation for their collaborative efforts and innovations serving society. Each laboratory, innovation, and partnership contributes significantly to the vision of Viksit Bharat. [1]
Addressing scientists from 165 VRDLs nationwide, Minister Patel highlighted their crucial role in sequencing viruses and validating nearly 1,700 diagnostic commodities. Moreover, 16 VRDLs now boast Bio-Safety Level-3 (BSL-3) facilities, enabling the study of high-risk pathogens. Consequently, these facilities play a central role in detecting outbreaks of diseases like Nipah, Zika, and Kyasanur Forest Disease. [1] The National Institute of Virology (NIV), Pune, stands as India’s sole BSL-4 lab. Furthermore, under the Ayushman Bharat Health Infrastructure Mission, four regional NIVs are being established in Jabalpur, Dibrugarh, Bangalore, and Jammu, thus enhancing preparedness across the country. [1, 4, 10]
Innovations in Disease Combat and Public Health
India’s health research ecosystem is generating innovative solutions for critical health challenges. For instance, the Minister shared India’s validated solutions for tuberculosis (TB). These include portable handheld X-ray machines for remote villages and DeepCXR, an AI-based screening tool trained on over 75,000 chest X-rays, now freely available for mass TB screening. Additionally, the CyTb skin test, priced at ₹199, aids in latent TB detection. PathoDetect™ offers rapid molecular diagnosis of TB and drug resistance, while a modified BPaL regimen achieves up to 90% cure for drug-resistant TB with fewer side effects. [1]
Efforts to eliminate sickle cell disease are also underway through the National Sickle Cell Anaemia Elimination Mission. This initiative has successfully reduced the cost of rapid diagnostic tests from Rs 300 to Rs 28, making diagnosis more accessible. [1] The role of HTAIn in optimizing healthcare costs and quality under Ayushman Bharat PM-JAY was also noted, with 855 health benefit packages revised based on cost data from 86 hospitals, benefiting millions. [1]
ICMR’s collaboration with CDSCO marks a pioneering step in developing standard protocols for IVDs, elevating validation standards and global competitiveness. Many VRDLs are also undergoing upgrades to become Medical Device Testing Laboratories. [1] The Minister released both the IVD validation portal and its protocols, emphasizing their contribution to faster, more transparent, and industry-friendly validation processes. [1] She also launched the first VRDL Bulletin, a tool for real-time tracking of viral infections, improving resource allocation. [1]
Towards a Resilient Health Research Ecosystem
Dr. Rajiv Bahl, Secretary, Department of Health Research (DHR) and DG, ICMR, emphasized the conclave’s role in unveiling transformative initiatives. These initiatives strengthen India’s ability to respond to viral outbreaks and health emergencies. He likened the VRDL network to India’s impenetrable bio-defence, similar to the nation’s air defence in Operation Sindoor. With 164 labs across 26 states and 5 Union Territories, VRDLs facilitate early detection, swift diagnosis, and prompt response, thereby significantly bolstering disease surveillance and emergency preparedness. [1, 11] Moreover, the National One Health Mission has integrated ten VRDLs into a National BSL-3 Network, uniting 13 departments under one umbrella, a global first. [1, 4, 15]
Dr. Rajeev Singh Raghuvanshi, Drug Controller General of India (DGCI), highlighted the CDSCO-ICMR collaboration in developing 39 standard evaluation protocols for high-risk IVDs, covering diseases such as TB, Malaria, and Nipah. This collaboration represents the first global partnership between a national regulatory authority and a research institute to standardize IVD assessment. [1] Finally, the Union Minister awarded 25 top-performing VRDLs (8 Gold, 17 Silver) for their excellence in disease detection and laboratory performance. [1]
Frequently Asked Questions
Q1: What is the primary purpose of the VRDL network in India?
The VRDL network’s primary purpose is to strengthen viral disease diagnosis, research, and surveillance across India, enabling timely identification of viruses during outbreaks and continuous monitoring of existing and new viral strains. [1, 2, 7]
Q2: How is India enhancing its preparedness for high-risk pathogens?
India is enhancing preparedness by equipping 16 VRDLs with Bio-Safety Level-3 (BSL-3) facilities for studying high-risk pathogens like Nipah, Zika, and Kyasanur Forest Disease. Additionally, four regional National Institutes of Virology (NIVs) are being established under the Ayushman Bharat Health Infrastructure Mission. [1, 4, 10]
Q3: What are some of the key innovations in tuberculosis diagnosis and treatment mentioned?
Key innovations for tuberculosis include portable handheld X-ray machines for remote villages, DeepCXR (an AI-based screening tool), the CyTb skin test for latent TB detection, PathoDetect™ for rapid molecular diagnosis and drug resistance, and a modified BPaL regimen for drug-resistant TB. [1]
References
- Our VRDLs Have Stood as Sentinels in Protecting the Nation: MoS Health AnupriyaPatel – ETHealthworld
- Viral Research and Diagnostic Laboratories – Wikipedia
- ICMR licenses nine breakthrough health technologies to industry partners including Biological E, Zydus – Medical Dialogues
- India’s virus research and diagnostic laboratory network has expanded to 164 labs: ICMR-NIV Director – The Hindu
- ICMR Licenses Nine Breakthrough Health Technologies to Industry Partners at India MedTech Expo 2025 – PIB
- ICMR issues licences to industry partners for 9 breakthrough techs – The Times of India
- ICMR Virus Research and Diagnostic Laboratories Dataset
- VRDL Scheme – DHR || ePMS
- ICMR Licenses Nine Medical Technologies to Industry Partners at India MedTech Expo 2025 – Newsonair
- Union Minister of State for Health and family Welfare, Smt. Anupriya Patel Inaugurates National Virus Research & Diagnostic Laboratory Conclave – PIB
- National Viral Research and Diagnostic laboratories protecting India from viruses, pathogens: Minister – Social News XYZ
- Virus Research and Diagnostic Laboratory (VRDL) ICMR-NICED
- First in the World Challenge, ICMR
- Home | Indian Council of Medical Research | Government of India
- Avian Influenza: First Global Dialogue Targets The Rising Pandemic Threat
- Welcome to Department of Biotechnology | Department of Biotechnology
Disclaimer: This article was automatically generated from publicly available sources and is provided for informational and educational purposes only. OC Academy does not exercise editorial control or claim authorship over this content. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider and refer to current local and national clinical guidelines.